L, B., T, R., & AF, S. (2026). Letter on 'Clinical Features of Portal Hypertension and Their Prognostic Implications in Patients With Autoimmune Hepatitis': Authors' Reply. Alimentary pharmacology & therapeutics, 63(7), 1070. https://doi.org/10.1111/apt.70518
Chicago Style (17th ed.) CitationL, Burghart, Reiberger T, and Stättermayer AF. "Letter on 'Clinical Features of Portal Hypertension and Their Prognostic Implications in Patients With Autoimmune Hepatitis': Authors' Reply." Alimentary Pharmacology & Therapeutics 63, no. 7 (2026): 1070. https://doi.org/10.1111/apt.70518.
MLA (9th ed.) CitationL, Burghart, et al. "Letter on 'Clinical Features of Portal Hypertension and Their Prognostic Implications in Patients With Autoimmune Hepatitis': Authors' Reply." Alimentary Pharmacology & Therapeutics, vol. 63, no. 7, 2026, p. 1070, https://doi.org/10.1111/apt.70518.